Letter to the Editor regarding COVID-19 outcomes in patients with dermatomyositis: A registry-based cohort analysis

Summary: This study aimed to compare the outcomes of COVID-19 in DM patients with a control group and identify the risk associations of gender, race, interstitial lung disease, neoplasms, and use of immunosuppressants. The results showed that DM patients with COVID-19 had lower mortality, hospitalization, severe COVID-19, acute kidney injury, and sepsis compared to the control group. However, males, African Americans, patients with interstitial lung disease, and those using DMARDs and glucocorticoids were associated with poorer COVID-19 outcomes.